T cell responses are governed by avidity and co‐stimulatory thresholds
- 1 September 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (9) , 2017-2022
- https://doi.org/10.1002/eji.1830260908
Abstract
We analyzed the avidity and CD28‐mediated co‐stimulatory requirements for the activation of T cells in vivo and in vitro. The strength of the T cell/antigen‐presenting cell interaction was varied by using altered peptide ligands for stimulation. Co‐stimulatory requirements were studied using T cells from CD28‐deficient mice. The results indicate that T cell activation is not an all‐or‐nothing event, but occurs in distinct steps. For each step, a certain avidity, co‐stimulatory threshold or both, must be met. Depending upon the strength of the interaction between the T cell receptor and the major histocompatibility complex/peptide and the presence of CD28 co‐stimulatory signals, T cells may undergo blast formation alone or proliferate or eventually both proliferate and differentiate to effector cells. Thus, T cell activation is governed by both avidity and co‐stimulatory thresholds.Keywords
This publication has 33 references indexed in Scilit:
- Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid OrgansScience, 1995
- Immunological function of a defined T-cell population tolerized to low-affinity self antigensNature, 1995
- The B7 and CD28 receptor familiesImmunology Today, 1994
- The lack of CD8α cytoplasmic domain resulted in a dramatic decrease in efficiency in thymic maturation but only a moderate reduction in cytotoxic function of CD8+ T lymphocytesEuropean Journal of Immunology, 1993
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Tolerance induction by clonal deletion of CD4+8+ thymocytes in vitro does not require dedicated antigen‐presenting cellsEuropean Journal of Immunology, 1993
- Autoimmune diabetes as a consequence of locally produced interleukin-2Nature, 1992
- Lower receptor avidity required for thymic clonal deletion than for effector T-cell functionNature, 1991
- Ligand thresholds at different stages of T cell developmentInternational Immunology, 1990
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984